The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent on the quality and completeness of data they gather from clinical trials and ...

I see early signs of a wealth rotation from growth to value. Read why this environment presents substantial alpha ...

In business, the power of individual leaders is an inherently hard thing to measure. It’s subjective, and it fluctuates on ...

The S&P 500 is at extreme, dot-com-level overvaluations, setting up for an inevitable market decline. Read what investors ...

It was about our premium positioning, which drove further expansion in our gross profit margin to 61.5% and our adjusted EBITDA margin to 18.2%. For example, fans saw Iga Swiatec win an incredible ...